(Bloomberg) -- Accenture Plc Chief Executive Officer Pierre Nanterme stepped down for health reasons about two years after having surgery for colon cancer.

Chief Financial Officer David Rowland was named interim CEO and also joined the board, Dublin-based Accenture said Friday in a statement. Rowland has been at the firm for 35 years, and was CFO since July 2013. Lead independent director Marge Magner was named non-executive chair, according to the statement.

Nanterme, who has held the top job since 2011 and also served as chairman, disclosed the surgery in July 2016. The company said Friday that the reasons for his departure were related to that announcement.

Accenture, a consulting and outsourcing firm that employs 469,000 people, said there was no change to the business outlook it gave last month for 2019.

“I’ve never been more confident in our business strategy, leadership team and people,” Nanterme, 59, said in the statement.

(Updates with Rowland’s tenure in second paragraph. An earlier version of this story corrected Magner’s title.)

To contact the reporter on this story: Ben Foldy in New York at bfoldy@bloomberg.net

To contact the editors responsible for this story: Michael J. Moore at mmoore55@bloomberg.net, Steve Dickson, Alan Mirabella

©2019 Bloomberg L.P.